184 related articles for article (PubMed ID: 20689254)
21. Bullous pemphigoid masquerading as recurrent vesicular hand eczema.
Veien NK
Acta Derm Venereol; 2010; 90(1):4-5. PubMed ID: 20107717
[No Abstract] [Full Text] [Related]
22. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.
Kromminga A; Scheckenbach C; Georgi M; Hagel C; Arndt R; Christophers E; Bröcker EB; Zillikens D
J Autoimmun; 2000 Nov; 15(3):293-300. PubMed ID: 11040070
[TBL] [Abstract][Full Text] [Related]
23. Anti-BP180 autoantibodies as a marker of poor prognosis in bullous pemphigoid: a cohort analysis of 94 elderly patients.
Bernard P; Bedane C; Bonnetblanc JM
Br J Dermatol; 1997 May; 136(5):694-8. PubMed ID: 9205501
[TBL] [Abstract][Full Text] [Related]
24. [Bullous pemphigoid: diagnostics and new therapeutic strategies].
Hofmann SC; Bruckner-Tuderman L
Dtsch Med Wochenschr; 2006 Feb; 131(8):389-92. PubMed ID: 16479471
[TBL] [Abstract][Full Text] [Related]
25. Two cases of childhood bullous pemphigoid.
Toyama T; Nakamura K; Kuramochi A; Ohyama B; Hashimoto T; Tsuchida T
Eur J Dermatol; 2009; 19(4):368-71. PubMed ID: 19451055
[TBL] [Abstract][Full Text] [Related]
26. Peristomal bullous pemphigoid.
Marzano AV; Vezzoli P; Colombo A; Serini SM; Crosti C; Berti E
J Dermatol; 2010 Sep; 37(9):840-2. PubMed ID: 20883375
[No Abstract] [Full Text] [Related]
27. Enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence testing in a bullous pemphigoid and pemphigoid gestationis.
Barnadas MA; Rubiales MV; González MJ; Puig L; García P; Baselga E; Pujol R; Alomar A; Gelpí C
Int J Dermatol; 2008 Dec; 47(12):1245-9. PubMed ID: 19126009
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort study.
Bernard P; Reguiai Z; Tancrède-Bohin E; Cordel N; Plantin P; Pauwels C; Vaillant L; Grange F; Richard-Lallemand MA; Sassolas B; Roujeau JC; Lok C; Picard-Dahan C; Chosidow O; Vitry F; Joly P
Arch Dermatol; 2009 May; 145(5):537-42. PubMed ID: 19451497
[TBL] [Abstract][Full Text] [Related]
29. Development of an ELISA for the detection of autoantibodies to BP230.
Kromminga A; Sitaru C; Hagel C; Herzog S; Zillikens D
Clin Immunol; 2004 Apr; 111(1):146-52. PubMed ID: 15093564
[TBL] [Abstract][Full Text] [Related]
30. Tetracycline and niacinamide control bullous pemphigoid but not pemphigus foliaceus when these conditions coexist.
Shiohara J; Yoshida K; Hasegawa J; Uhara H; Takata M; Saida T; Ohyama B; Hashimoto T
J Dermatol; 2010 Jul; 37(7):657-61. PubMed ID: 20629832
[TBL] [Abstract][Full Text] [Related]
31. IgE autoantibodies against the intracellular domain of BP180.
Dresow SK; Sitaru C; Recke A; Oostingh GJ; Zillikens D; Gibbs BF
Br J Dermatol; 2009 Feb; 160(2):429-32. PubMed ID: 18808416
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of ELISA testing for BP180 and BP230 as a diagnostic modality for bullous pemphigoid: a clinical experience.
Keller JJ; Kittridge AL; Debanne SM; Korman NJ
Arch Dermatol Res; 2016 May; 308(4):269-72. PubMed ID: 26895534
[TBL] [Abstract][Full Text] [Related]
33. Correlation of clinical severity and ELISA indices for the NC16A domain of BP180 measured using BP180 ELISA kit in bullous pemphigoid.
Tsuji-Abe Y; Akiyama M; Yamanaka Y; Kikuchi T; Sato-Matsumura KC; Shimizu H
J Dermatol Sci; 2005 Mar; 37(3):145-9. PubMed ID: 15734283
[TBL] [Abstract][Full Text] [Related]
34. Anti-p200 pemphigoid: a novel autoimmune subepidermal blistering disease.
Dilling A; Rose C; Hashimoto T; Zillikens D; Shimanovich I
J Dermatol; 2007 Jan; 34(1):1-8. PubMed ID: 17204094
[TBL] [Abstract][Full Text] [Related]
35. Absence of anti-BP180 antibodies in mothers of infants with bullous pemphigoid.
Chiavérini C; Hamel-Teillac D; Gilbert D; Prost Y
Br J Dermatol; 2006 May; 154(5):839-43. PubMed ID: 16634883
[TBL] [Abstract][Full Text] [Related]
36. Autoimmune vesicles on the face and neck. A variant of Brunsting-Perry type localized bullous pemphigoid?
Sugita Y; Inomata N; Takahashi Y; Yomoda M; Hashimoto T; Ikezawa Z
Eur J Dermatol; 2001; 11(6):557-9. PubMed ID: 11701408
[TBL] [Abstract][Full Text] [Related]
37. Serum levels of BAFF are increased in bullous pemphigoid but not in pemphigus vulgaris.
Asashima N; Fujimoto M; Watanabe R; Nakashima H; Yazawa N; Okochi H; Tamaki K
Br J Dermatol; 2006 Aug; 155(2):330-6. PubMed ID: 16882171
[TBL] [Abstract][Full Text] [Related]
38. Case of localized bullous pemphigoid with unique clinical manifestations in the lower legs.
Kohroh K; Suga Y; Mizuno Y; Ishii N; Hashimoto T; Ikeda S
J Dermatol; 2007 Jul; 34(7):482-5. PubMed ID: 17584328
[TBL] [Abstract][Full Text] [Related]
39. [Bullous pemphigoid].
Schulze F; Kasperkiewicz M; Zillikens D; Schmidt E
Hautarzt; 2013 Dec; 64(12):931-43; quiz 944-5. PubMed ID: 24337308
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic value of autoantibody titres in patients with bullous pemphigoid.
Eckardt J; Eberle FC; Ghoreschi K
Eur J Dermatol; 2018 Feb; 28(1):3-12. PubMed ID: 29336324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
